Reviewing MDxHealth (OTCMKTS:MXDHF) and SES (OTCMKTS:SGBAF)

SES (OTCMKTS:SGBAF) and MDxHealth (OTCMKTS:MXDHF) are both small-cap computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, profitability, analyst recommendations and valuation.

Analyst Ratings

This is a summary of recent ratings for SES and MDxHealth, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SES	0	0	0	1	4.00
MDxHealth	0	0	0	0	0.00

Given MDxHealth’s higher possible upside, analysts clearly believe MDxHealth is more favorable than SES.

Risk and Volatility

SES has a beta of 1.26, indicating that its share price is 26% more volatile than the S&P 500. Comparatively, MDxHealth has a beta of 1.46, indicating that its share price is 46% more volatile than the S&P 500.

Valuation & Earnings

This table compares SES and MDxHealth”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SES	$2.20 billion	0.81	-$974.59 million	($4.18)	-0.77
MDxHealth	$37.05 million	0.00	-$44.04 million	N/A	N/A

MDxHealth has lower revenue, but higher earnings than SES.

Profitability

This table compares SES and MDxHealth’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
SES	-83.41%	6.16%	2.35%
MDxHealth	N/A	N/A	N/A

Summary

SES beats MDxHealth on 5 of the 9 factors compared between the two stocks.

About SES

SES S.A. provides satellite-based data transmission capacity and ancillary services worldwide. The company offers content connectivity solutions, including network spanning satellite and ground infrastructure to create, deliver, and manage video and data solutions. It also provides data connectivity services through its fleet of geostationary earth orbit and medium earth orbit satellites to the aviation, cloud, cruise, energy, government, maritime, and telco and mobile network operator industries. In addition, the company offers video services, which includes end-to-end managed services to audience; and provides multi-screen and multi-device viewing experiences on linear channels, video-on-demand, streaming platforms, and social media sites for broadcasters, platform operators, and sports organizations. Further, it provides linear video aggregation and distribution, such as direct-to-home, direct-to-cable, and internet protocol TV households; channel management solutions comprising playout; and live feeds and redundancy features. The company was formerly known as SES Global SA and changed its name to SES S.A. in December 2006. SES S.A. was founded in 1985 and is headquartered in Betzdorf, Luxembourg.

About MDxHealth

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.